Gregorio Brevetti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gregorio Brevetti has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Massimo Chiariello
19 shared publicationsVittorio Schiano
12 shared publicationsFrancesco Scopacasa
8 shared publicationsAntonio Silvestro
6 shared publicationsEugenio Laurenzano
Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples ‘Federico II’, Naples, Italy
6 shared publications- Giuseppe Giugliano
Department of Advanced Biomedical Sciences, Federico II University of Naples, 80131 Naples, Italy
6 shared publications
Latest Publications
- 1 June 2009
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 49 (6) , 1465-1471
Concomitant coronary and peripheral arterial disease: Relationship between the inflammatory status of the affected limb and the severity of coronary artery disease
- 1 June 2009
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 49 (6) , 1465-1471
Concomitant coronary and peripheral arterial disease: Relationship between the inflammatory status of the affected limb and the severity of coronary artery disease
- Open Access
- 30 March 2009
- Published by PAGEPress Publications
- Vol. 72 (1)
Carotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation.
Although during the last decade there have been great advances in our knowledge of the epidemiology and pathophysiology of multi-district atherosclerotic disease, little is known about the association between peripheral arterial disease and carotid artery disease. This review was conceived to cast some light on this topic, paying special attention to inflammation which plays a pivotal role in atherosclerosis. An aspect of pathophysiologic and clinical relevance is that the coexistence of carotid disease is more frequent in peripheral arterial disease than in coronary artery disease, not only in terms of carotid stenosis, but also with respect to the presence of hypoechoic unstable plaque. These latter plaques present a large infiltration of macrophages and are associated to high levels of inflammatory markers. In particular, the greater prevalence of hypoechoic carotid plaques in peripheral arterial disease compared to patients with carotid artery disease was poorly related to classic risk factors, but showed an independent association with an increased number of leukocyte and neutrophil cells, which are reliable markers of inflammation. The greater prevalence of hypoechoic unstable carotid plaques could explain why peripheral arterial disease portends higher risk of stroke than coronary artery disease.
- 30 March 2009
- Published by PAGEPress Publications
- Vol. 72 (1)
Open AccessCarotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation.
Although during the last decade there have been great advances in our knowledge of the epidemiology and pathophysiology of multi-district atherosclerotic disease, little is known about the association between peripheral arterial disease and carotid artery disease. This review was conceived to cast some light on this topic, paying special attention to inflammation which plays a pivotal role in atherosclerosis. An aspect of pathophysiologic and clinical relevance is that the coexistence of carotid disease is more frequent in peripheral arterial disease than in coronary artery disease, not only in terms of carotid stenosis, but also with respect to the presence of hypoechoic unstable plaque. These latter plaques present a large infiltration of macrophages and are associated to high levels of inflammatory markers. In particular, the greater prevalence of hypoechoic carotid plaques in peripheral arterial disease compared to patients with carotid artery disease was poorly related to classic risk factors, but showed an independent association with an increased number of leukocyte and neutrophil cells, which are reliable markers of inflammation. The greater prevalence of hypoechoic unstable carotid plaques could explain why peripheral arterial disease portends higher risk of stroke than coronary artery disease.
- Open Access
- 1 February 2009
- Published by SAGE Publications in Vascular Medicine
- Vol. 14 (1) , 13-19
Prevalence of hypoechoic carotid plaques in coronary artery disease: relationship with coexistent peripheral arterial disease and leukocyte number
In coronary artery disease (CAD), a concomitant peripheral arterial disease (PAD) entails a more severe coronary atherosclerosis. We hypothesized that the severity of carotid artery disease is greater in CAD+PAD than in CAD alone. In 90 CAD and 79 CAD+PAD patients, carotid plaque echolucency was measured by gray-scale median (GSM), and the degree of carotid stenosis by routine Doppler criteria. Plaques were absent in 20 (22.2%) CAD and 8 (10.1%) CAD+PAD patients (p = 0.035), while the prevalence of carotid stenosis ≥ 50% was 16.7% and 25.3%, respectively (p = 0.166). The GSM score was 45.1 [21.7–67.7] in CAD+PAD vs 60.1 [44.9–83.1] in CAD alone (p < 0.001). Consistently, hypoechoic plaques (GSM < 25th percentile) were more common in CAD+PAD than in CAD patients (38.0% vs 11.4%, p < 0.001). On multivariate analysis, CAD+PAD was the only variable significantly associated with hypoechoic plaques (OR = 4.16, 95% CI 1.68–10.28). However, when the leukocyte count was added to the model, it showed the strongest association with hypoechoic plaques (OR = 6.70, 95% CI 2.13–21.10). In conclusion, compared with CAD alone patients, those with concomitant PAD showed a greater prevalence of plaques with characteristics of instability. Thus, our data suggest that in CAD+PAD, evaluation of carotid plaque echogenicity could contribute to improve clinical decision-making and differentiate treatments for individual patients.
- 1 February 2009
- Published by SAGE Publications in Vascular Medicine
- Vol. 14 (1) , 13-19
Open AccessPrevalence of hypoechoic carotid plaques in coronary artery disease: relationship with coexistent peripheral arterial disease and leukocyte number
In coronary artery disease (CAD), a concomitant peripheral arterial disease (PAD) entails a more severe coronary atherosclerosis. We hypothesized that the severity of carotid artery disease is greater in CAD+PAD than in CAD alone. In 90 CAD and 79 CAD+PAD patients, carotid plaque echolucency was measured by gray-scale median (GSM), and the degree of carotid stenosis by routine Doppler criteria. Plaques were absent in 20 (22.2%) CAD and 8 (10.1%) CAD+PAD patients (p = 0.035), while the prevalence of carotid stenosis ≥ 50% was 16.7% and 25.3%, respectively (p = 0.166). The GSM score was 45.1 [21.7–67.7] in CAD+PAD vs 60.1 [44.9–83.1] in CAD alone (p < 0.001). Consistently, hypoechoic plaques (GSM < 25th percentile) were more common in CAD+PAD than in CAD patients (38.0% vs 11.4%, p < 0.001). On multivariate analysis, CAD+PAD was the only variable significantly associated with hypoechoic plaques (OR = 4.16, 95% CI 1.68–10.28). However, when the leukocyte count was added to the model, it showed the strongest association with hypoechoic plaques (OR = 6.70, 95% CI 2.13–21.10). In conclusion, compared with CAD alone patients, those with concomitant PAD showed a greater prevalence of plaques with characteristics of instability. Thus, our data suggest that in CAD+PAD, evaluation of carotid plaque echogenicity could contribute to improve clinical decision-making and differentiate treatments for individual patients.
- 1 December 2008
- Published by Elsevier in Atherosclerosis
- Vol. 201 (2) , 440-446
In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction
- 1 December 2008
- Published by Elsevier in Atherosclerosis
- Vol. 201 (2) , 440-446
In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction
- 12 November 2008
- Published by Wiley in Clinical Endocrinology
- Vol. 69 (6) , 894-900
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb
Summary: Objectives IGF‐1 and its binding proteins are involved in the pathogenesis of atherosclerosis. We designed this study to unravel the relationship of the IGF system with peripheral arterial disease (PAD).Design Case‐control, cross‐sectional study.Measurements Serum levels of IGF‐1, IGFBP‐3 and acid labile subunit (ALS) were measured in 96 PAD patients and 89 controls. In 28 patients who underwent peripheral angiography, C‐reactive protein (CRP), IGF‐1, IGFBP‐3 and ALS were measured in blood from femoral vein of the affected limb and aorta.Results Compared to controls, PAD patients showed lower levels of IGFBP‐3 (3569 ± 115vs.3106 ± 107 µg/l,P < 0·01), and ALS (12·2 ± 0·5vs.8·3 ± 0·5 mg/l,P < 0·01). In PAD, concentrations of IGFBP‐3 and ALS were significantly lower in patients with ankle/brachial index less than median than in those with a less severe PAD. In the affected limb, CRP venous‐arterial difference correlated negatively with that of IGF‐1 (ρ = −0·57,P < 0·01), and positively with that of IGFBP‐3 (ρ = 0·63,P < 0·01). At multivariate analysis, a high transfemoral gradient of CRP was independently associated with a low transfemoral gradient of IGF‐1 (β coefficient = −0·48,P < 0·01), and a high transfemoral gradient of IGFBP‐3 (β coefficient = 0·22,P < 0·05).Conclusions This study is the first to demonstrate that the systemic levels of IGF axis components are associated with the presence and severity of PAD, and that the inflammatory status of the ischaemic limb affects the transfemoral concentrations of IGF‐1 and IGFBP‐3. Due to the importance of IGF axis in modulating atherosclerotic plaque progression, our data may contribute to a better understanding of PAD pathophysiology.
- 12 November 2008
- Published by Wiley in Clinical Endocrinology
- Vol. 69 (6) , 894-900
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb
Summary: Objectives IGF‐1 and its binding proteins are involved in the pathogenesis of atherosclerosis. We designed this study to unravel the relationship of the IGF system with peripheral arterial disease (PAD).Design Case‐control, cross‐sectional study.Measurements Serum levels of IGF‐1, IGFBP‐3 and acid labile subunit (ALS) were measured in 96 PAD patients and 89 controls. In 28 patients who underwent peripheral angiography, C‐reactive protein (CRP), IGF‐1, IGFBP‐3 and ALS were measured in blood from femoral vein of the affected limb and aorta.Results Compared to controls, PAD patients showed lower levels of IGFBP‐3 (3569 ± 115vs.3106 ± 107 µg/l,P < 0·01), and ALS (12·2 ± 0·5vs.8·3 ± 0·5 mg/l,P < 0·01). In PAD, concentrations of IGFBP‐3 and ALS were significantly lower in patients with ankle/brachial index less than median than in those with a less severe PAD. In the affected limb, CRP venous‐arterial difference correlated negatively with that of IGF‐1 (ρ = −0·57,P < 0·01), and positively with that of IGFBP‐3 (ρ = 0·63,P < 0·01). At multivariate analysis, a high transfemoral gradient of CRP was independently associated with a low transfemoral gradient of IGF‐1 (β coefficient = −0·48,P < 0·01), and a high transfemoral gradient of IGFBP‐3 (β coefficient = 0·22,P < 0·05).Conclusions This study is the first to demonstrate that the systemic levels of IGF axis components are associated with the presence and severity of PAD, and that the inflammatory status of the ischaemic limb affects the transfemoral concentrations of IGF‐1 and IGFBP‐3. Due to the importance of IGF axis in modulating atherosclerotic plaque progression, our data may contribute to a better understanding of PAD pathophysiology.
- 1 April 2008
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 9 (4) , 382-388
Women and peripheral arterial disease: same disease, different issues
Atherosclerosis is a multifactorial disease and, thus, its clinical manifestations are likely to present gender-specific differences with respect to their development, course, symptom complexes and prognosis. The present study aimed to examine sex differences in peripheral arterial disease (PAD) and its clinical correlates. PAD severity, quality of life (assessed by ST-22), cardiovascular risk factors, inflammatory profile and comorbidity were assessed in 163 men and 68 women who were consecutively diagnosed with PAD at three Italian University vascular centres. Compared to men, women showed a higher prevalence of critical limb ischemia (P = 0.018), but had a less impaired quality of life (assessed by ST-22), and were less likely to have a history of lower extremity revascularization. Furthermore, women tended to be older (P = 0.058), and more likely to present hypercholesterolemia (P = 0.053), diabetes mellitus (P = 0.001), body mass index > or = 30 kg/m2 (P = 0.003) and metabolic syndrome (P = 0.001). Conversely, C-reactive protein plasma levels were similar in the two groups. No gender-specific difference was observed in cardiovascular comorbidity; however, the condition showing the strongest association with coronary artery disease was diabetes mellitus in women (odds ratio = 4.96, P = 0.021), and smoking in men (odds ratio = 2.66, P = 0.008). In PAD, there are several sex differences in baseline characteristics, especially with respect to the weight and significance of cardiovascular risk factors. Knowledge of these differences may help achieve optimal gender-specific cardiovascular risk prevention.
- 1 April 2008
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 9 (4) , 382-388
Women and peripheral arterial disease: same disease, different issues
Atherosclerosis is a multifactorial disease and, thus, its clinical manifestations are likely to present gender-specific differences with respect to their development, course, symptom complexes and prognosis. The present study aimed to examine sex differences in peripheral arterial disease (PAD) and its clinical correlates. PAD severity, quality of life (assessed by ST-22), cardiovascular risk factors, inflammatory profile and comorbidity were assessed in 163 men and 68 women who were consecutively diagnosed with PAD at three Italian University vascular centres. Compared to men, women showed a higher prevalence of critical limb ischemia (P = 0.018), but had a less impaired quality of life (assessed by ST-22), and were less likely to have a history of lower extremity revascularization. Furthermore, women tended to be older (P = 0.058), and more likely to present hypercholesterolemia (P = 0.053), diabetes mellitus (P = 0.001), body mass index > or = 30 kg/m2 (P = 0.003) and metabolic syndrome (P = 0.001). Conversely, C-reactive protein plasma levels were similar in the two groups. No gender-specific difference was observed in cardiovascular comorbidity; however, the condition showing the strongest association with coronary artery disease was diabetes mellitus in women (odds ratio = 4.96, P = 0.021), and smoking in men (odds ratio = 2.66, P = 0.008). In PAD, there are several sex differences in baseline characteristics, especially with respect to the weight and significance of cardiovascular risk factors. Knowledge of these differences may help achieve optimal gender-specific cardiovascular risk prevention.
- Open Access
- 4 March 2008
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 101 (7) , 575-582
The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study
Background: A comprehensive evaluation of comorbidity is important in predicting outcome of patients affected by a chronic disease because of the role of competing risk. Aim: To assess the prognostic impact of the Cumulative Illness Rating Scale (CIRS) on the cardiovascular risk of subjects participating in the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. Design: Prospective study. Methods: The study included 60 patients with peripheral arterial disease (PAD) and 163 no-PAD subjects. CIRS-illness severity (IS) score and CIRS-comorbidity index (CI) were calculated. Results: After a 42-month follow-up, 18/223 participants had a myocardial infarction or stroke. These subjects had a higher CIRS-IS score (1.99 ± 0.52 vs. 1.71 ± 0.37, P = 0.003) and a higher CIRS-CI (4.00 ± 2.81 vs. 2.65 ± 1.85, P = 0.005) vs. the 205 subjects without event. However, the significant association of CIRS scores with the outcome disappeared when conditions considered to be ‘concordant’ with the endpoint were excluded from the calculation of the scores. Importantly, among the 163 no-PAD subjects CIRS scores did not differ between those with and without an event. Conversely, in the 60 PAD patients, the CIRS-IS score calculated excluding the ‘concordant’ conditions was associated with an increased cardiovascular risk (RR = 4.03, 95% confidence interval (CI) 1.05–15.37, P = 0.042) after adjustment for potential confounders. The corresponding RR for the CIRS-CI was 1.43 (95% CI 1.03–1.98, P = 0.032). Furthermore, both CIRS scores improved the predictive value of ankle/brachial index, which is the most powerful prognostic indicator in PAD. Conclusions: Our findings indicate that overall comorbidity, and not only cardiovascular comorbidity, must be considered for prediction of myocardial infarction and stroke in PAD.
- 4 March 2008
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 101 (7) , 575-582
Open AccessThe impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study
Background: A comprehensive evaluation of comorbidity is important in predicting outcome of patients affected by a chronic disease because of the role of competing risk. Aim: To assess the prognostic impact of the Cumulative Illness Rating Scale (CIRS) on the cardiovascular risk of subjects participating in the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. Design: Prospective study. Methods: The study included 60 patients with peripheral arterial disease (PAD) and 163 no-PAD subjects. CIRS-illness severity (IS) score and CIRS-comorbidity index (CI) were calculated. Results: After a 42-month follow-up, 18/223 participants had a myocardial infarction or stroke. These subjects had a higher CIRS-IS score (1.99 ± 0.52 vs. 1.71 ± 0.37, P = 0.003) and a higher CIRS-CI (4.00 ± 2.81 vs. 2.65 ± 1.85, P = 0.005) vs. the 205 subjects without event. However, the significant association of CIRS scores with the outcome disappeared when conditions considered to be ‘concordant’ with the endpoint were excluded from the calculation of the scores. Importantly, among the 163 no-PAD subjects CIRS scores did not differ between those with and without an event. Conversely, in the 60 PAD patients, the CIRS-IS score calculated excluding the ‘concordant’ conditions was associated with an increased cardiovascular risk (RR = 4.03, 95% confidence interval (CI) 1.05–15.37, P = 0.042) after adjustment for potential confounders. The corresponding RR for the CIRS-CI was 1.43 (95% CI 1.03–1.98, P = 0.032). Furthermore, both CIRS scores improved the predictive value of ankle/brachial index, which is the most powerful prognostic indicator in PAD. Conclusions: Our findings indicate that overall comorbidity, and not only cardiovascular comorbidity, must be considered for prediction of myocardial infarction and stroke in PAD.
- 1 March 2008
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 47 (3) , 523-529
The prevalence of hypoechoic carotid plaques is greater in peripheral than in coronary artery disease and is related to the neutrophil count
- 1 March 2008
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 47 (3) , 523-529
The prevalence of hypoechoic carotid plaques is greater in peripheral than in coronary artery disease and is related to the neutrophil count
- 1 March 2008
- Published by Elsevier in Atherosclerosis
- Vol. 197 (1) , 1-11
Endothelial dysfunction: A key to the pathophysiology and natural history of peripheral arterial disease?
- 1 March 2008
- Published by Elsevier in Atherosclerosis
- Vol. 197 (1) , 1-11
Endothelial dysfunction: A key to the pathophysiology and natural history of peripheral arterial disease?
- Open Access
- 12 December 2007
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 29 (2) , 224-230
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease
The prognostic role of inflammation in peripheral arterial disease (PAD) remains to be conclusively established. Accordingly, in these patients we investigated the impact of myeloperoxidase (MPOx) and C-reactive protein on the incidence of myocardial infarction and stroke. Of 156 PAD patients, 10 had a myocardial infarction and seven a stroke, during follow-up. We used the receiver operating characteristic curve analysis and the bootstrap approach to identify the MPOx, C-reactive protein, and ankle brachial index (ABI) threshold levels that provided the best cut-off to predict the outcome. For MPOx a cut-off ≥183.7 pM was independently associated with a poor outcome (HR = 6.80, 95% CI 1.20–38.69, P = 0.031). The result remained unmodified when MPOx was used as a continuous variable (HR = 1.03, 95% CI 1.01–1.05, P = 0.031). Conversely, C-reactive protein was not a prognostic determinant in our series (HR = 0.88, 95% CI 0.60–1.29, P = 0.514). Kaplan–Meier curves for the four groups of patients delineated according to ABI and MPOx values identified using the bootstrap approach showed that the addition of MPOx measurement to ABI improved the ability to identify patients at risk for myocardial infarction and stroke. In PAD, MPOx, but not C-reactive protein, predicts an increased risk of major cardiovascular events, and adds to the prognostic value of ABI, currently the most powerful prognostic indicator in these patients.
- 12 December 2007
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 29 (2) , 224-230
Open AccessMyeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease
The prognostic role of inflammation in peripheral arterial disease (PAD) remains to be conclusively established. Accordingly, in these patients we investigated the impact of myeloperoxidase (MPOx) and C-reactive protein on the incidence of myocardial infarction and stroke. Of 156 PAD patients, 10 had a myocardial infarction and seven a stroke, during follow-up. We used the receiver operating characteristic curve analysis and the bootstrap approach to identify the MPOx, C-reactive protein, and ankle brachial index (ABI) threshold levels that provided the best cut-off to predict the outcome. For MPOx a cut-off ≥183.7 pM was independently associated with a poor outcome (HR = 6.80, 95% CI 1.20–38.69, P = 0.031). The result remained unmodified when MPOx was used as a continuous variable (HR = 1.03, 95% CI 1.01–1.05, P = 0.031). Conversely, C-reactive protein was not a prognostic determinant in our series (HR = 0.88, 95% CI 0.60–1.29, P = 0.514). Kaplan–Meier curves for the four groups of patients delineated according to ABI and MPOx values identified using the bootstrap approach showed that the addition of MPOx measurement to ABI improved the ability to identify patients at risk for myocardial infarction and stroke. In PAD, MPOx, but not C-reactive protein, predicts an increased risk of major cardiovascular events, and adds to the prognostic value of ABI, currently the most powerful prognostic indicator in these patients.